Key Points

  • Substantive familial risks are associated with each hematological malignancy, younger diagnosis age, and multiple affected relatives.

  • The familial relative risks provide evidence for shared etiology between the specific hematological malignancies.

Abstract

Estimating familial cancer risks is clinically important in being able to discriminate between individuals in the population at differing risk for malignancy. To gain insight into the familial risk for the different hematological malignancies and their possible inter-relationship, we analyzed data on more than 16 million individuals from the Swedish Family-Cancer Database. After identifying 153 115 patients diagnosed with a primary hematological malignancy, we quantified familial relative risks (FRRs) by calculating standardized incident ratios (SIRs) in 391 131 of their first-degree relatives. The majority of hematological malignancies showed increased FRRs for the same tumor type, with the highest FRRs being observed for mixed cellularity Hodgkin lymphoma (SIR, 16.7), lymphoplasmacytic lymphoma (SIR, 15.8), and mantle cell lymphoma (SIR, 13.3). There was evidence for pleiotropic relationships; notably, chronic lymphocytic leukemia was associated with an elevated familial risk for other B-cell tumors and myeloproliferative neoplasms. Collectively, these data provide evidence for shared etiological factors for many hematological malignancies and provide information for identifying individuals at increased risk, as well as informing future gene discovery initiatives.

REFERENCES

REFERENCES
1.
Swerdlow
SH
,
Campo
E
,
Pileri
SA
, et al
.
The 2016 revision of the World Health Organization classification of lymphoid neoplasms
.
Blood
.
2016
;
127
(
20
):
2375
-
2390
.
2.
Arber
DA
,
Orazi
A
,
Hasserjian
R
, et al
.
The 2016 revision to the World Health Organization classification of myeloid neoplasms and acute leukemia
.
Blood
.
2016
;
127
(
20
):
2391
-
2405
.
3.
Sant
M
,
Allemani
C
,
Tereanu
C
, et al;
HAEMACARE Working Group
.
Incidence of hematologic malignancies in Europe by morphologic subtype: results of the HAEMACARE project
.
Blood
.
2010
;
116
(
19
):
3724
-
3734
.
4.
Hjalgrim
H
,
Askling
J
,
Rostgaard
K
, et al
.
Characteristics of Hodgkin’s lymphoma after infectious mononucleosis
.
N Engl J Med
.
2003
;
349
(
14
):
1324
-
1332
.
5.
Epstein
MA
,
Achong
BG
,
Barr
YM
.
Virus particles in cultured lymphoblasts from Burkitt’s lymphoma
.
Lancet
.
1964
;
1
(
7335
):
702
-
703
.
6.
Wyatt
JI
,
Rathbone
BJ
.
Immune Response of the Gastric Mucosa to Campylobacter pylori
.
Scand J Gastroenterol Suppl
.
1988
;
142
:
44
-
49
.
7.
Poiesz
BJ
,
Ruscetti
FW
,
Gazdar
AF
,
Bunn
PA
,
Minna
JD
,
Gallo
RC
.
Detection and isolation of type C retrovirus particles from fresh and cultured lymphocytes of a patient with cutaneous T-cell lymphoma
.
Proc Natl Acad Sci USA
.
1980
;
77
(
12
):
7415
-
7419
.
8.
Ziegler
JL
,
Beckstead
JA
,
Volberding
PA
, et al
.
Non-Hodgkin’s lymphoma in 90 homosexual men. Relation to generalized lymphadenopathy and the acquired immunodeficiency syndrome
.
N Engl J Med
.
1984
;
311
(
9
):
565
-
570
.
9.
Grogg
KL
,
Miller
RF
,
Dogan
A
.
HIV infection and lymphoma
.
J Clin Pathol
.
2007
;
60
(
12
):
1365
-
1372
.
10.
Allan
JM
,
Travis
LB
.
Mechanisms of therapy-related carcinogenesis
.
Nat Rev Cancer
.
2005
;
5
(
12
):
943
-
955
.
11.
Hsu
W-L
,
Preston
DL
,
Soda
M
, et al
.
The incidence of leukemia, lymphoma and multiple myeloma among atomic bomb survivors: 1950-2001
.
Radiat Res
.
2013
;
179
(
3
):
361
-
382
.
12.
Fircanis
S
,
Merriam
P
,
Khan
N
,
Castillo
JJ
.
The relation between cigarette smoking and risk of acute myeloid leukemia: an updated meta-analysis of epidemiological studies
.
Am J Hematol
.
2014
;
89
(
8
):
E125
-
E132
.
13.
Cocco
P
,
Vermeulen
R
,
Flore
V
, et al
.
Occupational exposure to trichloroethylene and risk of non-Hodgkin lymphoma and its major subtypes: a pooled InterLymph analysis
.
Occup Environ Med
.
2013
;
70
(
11
):
795
-
802
.
14.
’t Mannetje A, De Roos AJ, Boffetta P, et al. Occupation and risk of non-Hodgkin lymphoma and its subtypes: a pooled analysis from the InterLymph Consortium. Environ Health Perspect.
2016
;124(4):396-405.
15.
Fallah
M
,
Kharazmi
E
,
Pukkala
E
, et al
.
Familial risk of non-Hodgkin lymphoma by sex, relationship, age at diagnosis and histology: a joint study from five Nordic countries
.
Leukemia
.
2016
;
30
(
2
):
373
-
378
.
16.
Kharazmi
E
,
Fallah
M
,
Pukkala
E
, et al
.
Risk of familial classical Hodgkin lymphoma by relationship, histology, age, and sex: a joint study from five Nordic countries
.
Blood
.
2015
;
126
(
17
):
1990
-
1995
.
17.
Kharazmi
E
,
da Silva Filho
MI
,
Pukkala
E
,
Sundquist
K
,
Thomsen
H
,
Hemminki
K
.
Familial risks for childhood acute lymphocytic leukaemia in Sweden and Finland: far exceeding the effects of known germline variants
.
Br J Haematol
.
2012
;
159
(
5
):
585
-
588
.
18.
Sud
A
,
Chattopadhyay
S
,
Thomsen
H
, et al
.
Familial risks of acute myeloid leukemia, myelodysplastic syndromes, and myeloproliferative neoplasms
.
Blood
.
2018
;
132
(
9
):
973
-
976
.
19.
Godley
LA
,
Shimamura
A
.
Genetic predisposition to hematologic malignancies: management and surveillance
.
Blood
.
2017
;
130
(
4
):
424
-
432
.
20.
Ceccaldi
R
,
Sarangi
P
,
D’Andrea
AD
.
The Fanconi anaemia pathway: new players and new functions
.
Nat Rev Mol Cell Biol
.
2016
;
17
(
6
):
337
-
349
.
21.
Sakamoto
KM
,
Narla
A
.
Perspective on Diamond-Blackfan anemia: lessons from a rare congenital bone marrow failure syndrome
.
Leukemia
.
2018
;
32
(
2
):
249
-
251
.
22.
Dokal
I
.
Dyskeratosis congenita
.
Hematology Am Soc Hematol Educ Program
.
2011
;
2011
:
480
-
486
.
23.
Noris
P
,
Perrotta
S
,
Seri
M
, et al
.
Mutations in ANKRD26 are responsible for a frequent form of inherited thrombocytopenia: analysis of 78 patients from 21 families
.
Blood
.
2011
;
117
(
24
):
6673
-
6680
.
24.
Smith
ML
,
Cavenagh
JD
,
Lister
TA
,
Fitzgibbon
J
.
Mutation of CEBPA in familial acute myeloid leukemia
.
N Engl J Med
.
2004
;
351
(
23
):
2403
-
2407
.
25.
Polprasert
C
,
Schulze
I
,
Sekeres
MA
, et al
.
Inherited and somatic defects in DDX41 in myeloid neoplasms
.
Cancer Cell
.
2015
;
27
(
5
):
658
-
670
.
26.
Horwitz
M
,
Benson
KF
,
Person
RE
,
Aprikyan
AG
,
Dale
DC
.
Mutations in ELA2, encoding neutrophil elastase, define a 21-day biological clock in cyclic haematopoiesis
.
Nat Genet
.
1999
;
23
(
4
):
433
-
436
.
27.
Feurstein
S
,
Godley
LA
.
Germline ETV6 mutations and predisposition to hematological malignancies
.
Int J Hematol
.
2017
;
106
(
2
):
189
-
195
.
28.
Hahn
CN
,
Chong
C-E
,
Carmichael
CL
, et al
.
Heritable GATA2 mutations associated with familial myelodysplastic syndrome and acute myeloid leukemia
.
Nat Genet
.
2011
;
43
(
10
):
1012
-
1017
.
29.
Klein
C
,
Grudzien
M
,
Appaswamy
G
, et al
.
HAX1 deficiency causes autosomal recessive severe congenital neutropenia (Kostmann disease)
.
Nat Genet
.
2007
;
39
(
1
):
86
-
92
.
30.
Antony-Debré
I
,
Manchev
VT
,
Balayn
N
, et al
.
Level of RUNX1 activity is critical for leukemic predisposition but not for thrombocytopenia
.
Blood
.
2015
;
125
(
6
):
930
-
940
.
31.
Narumi
S
,
Amano
N
,
Ishii
T
, et al
.
SAMD9 mutations cause a novel multisystem disorder, MIRAGE syndrome, and are associated with loss of chromosome 7
.
Nat Genet
.
2016
;
48
(
7
):
792
-
797
.
32.
Tesi
B
,
Davidsson
J
,
Voss
M
, et al
.
Gain-of-function SAMD9L mutations cause a syndrome of cytopenia, immunodeficiency, MDS, and neurological symptoms
.
Blood
.
2017
;
129
(
16
):
2266
-
2279
.
33.
Kirwan
M
,
Walne
AJ
,
Plagnol
V
, et al
.
Exome sequencing identifies autosomal-dominant SRP72 mutations associated with familial aplasia and myelodysplasia
.
Am J Hum Genet
.
2012
;
90
(
5
):
888
-
892
.
34.
Wei
X
,
Calvo-Vidal
MN
,
Chen
S
, et al
.
Germline lysine-specific demethylase 1 (LSD1/KDM1A) mutations confer susceptibility to multiple myeloma
.
Cancer Res
.
2018
;
78
(
10
):
2747
-
2759
.
35.
Vijayakrishnan
J
,
Kumar
R
,
Henrion
MYR
, et al
.
A genome-wide association study identifies risk loci for childhood acute lymphoblastic leukemia at 10q26.13 and 12q23.1
.
Leukemia
.
2017
;
31
(
3
):
573
-
579
.
36.
Sud
A
,
Thomsen
H
,
Law
PJ
, et al;
PRACTICAL consortium
.
Genome-wide association study of classical Hodgkin lymphoma identifies key regulators of disease susceptibility [published correction appears in Nat Commun. 2019;10(1):157]
.
Nat Commun
.
2017
;
8
(
1
):
1892
.
37.
Sud
A
,
Thomsen
H
,
Orlando
G
, et al;
PRACTICAL Consortium
.
Genome-wide association study implicates immune dysfunction in the development of Hodgkin lymphoma
.
Blood
.
2018
;
132
(
19
):
2040
-
2052
.
38.
Cerhan
JR
,
Berndt
SI
,
Vijai
J
, et al
.
Genome-wide association study identifies multiple susceptibility loci for diffuse large B cell lymphoma
.
Nat Genet
.
2014
;
46
(
11
):
1233
-
1238
.
39.
Labreche
K
,
Daniau
M
,
Sud
A
, et al;
LOC Network
.
A genome-wide association study identifies susceptibility loci for primary central nervous system lymphoma at 6p25.3 and 3p22.1: a LOC network study
.
Neuro-oncol
.
2019
;
noz088
.
40.
Skibola
CF
,
Berndt
SI
,
Vijai
J
, et al
.
Genome-wide association study identifies five susceptibility loci for follicular lymphoma outside the HLA region
.
Am J Hum Genet
.
2014
;
95
(
4
):
462
-
471
.
41.
Vijai
J
,
Wang
Z
,
Berndt
SI
, et al
.
A genome-wide association study of marginal zone lymphoma shows association to the HLA region
.
Nat Commun
.
2015
;
6
(
1
):
5751
.
42.
McMaster
ML
,
Berndt
SI
,
Zhang
J
, et al
.
Two high-risk susceptibility loci at 6p25.3 and 14q32.13 for Waldenström macroglobulinemia
.
Nat Commun
.
2018
;
9
(
1
):
4182
.
43.
Law
PJ
,
Berndt
SI
,
Speedy
HE
, et al
.
Genome-wide association analysis implicates dysregulation of immunity genes in chronic lymphocytic leukaemia
.
Nat Commun
.
2017
;
8
(
1
):
14175
.
44.
Went
M
,
Sud
A
,
Försti
A
, et al;
PRACTICAL consortium
.
Identification of multiple risk loci and regulatory mechanisms influencing susceptibility to multiple myeloma [published correction appears in Nat Commun. 2019;10(1):213]
.
Nat Commun
.
2018
;
9
(
1
):
3707
.
45.
Tapper
W
,
Jones
AV
,
Kralovics
R
, et al
.
Genetic variation at MECOM, TERT, JAK2 and HBS1L-MYB predisposes to myeloproliferative neoplasms
.
Nat Commun
.
2015
;
6
(
1
):
6691
.
46.
Hemminki
K
,
Eng
C
.
Clinical genetic counselling for familial cancers requires reliable data on familial cancer risks and general action plans
.
J Med Genet
.
2004
;
41
(
11
):
801
-
807
.
47.
Valberg
M
,
Stensrud
MJ
,
Aalen
OO
.
The surprising implications of familial association in disease risk
.
BMC Public Health
.
2018
;
18
(
1
):
135
.
48.
Kohlmann
W
,
Schiffman
JD
.
Discussing and managing hematologic germ line variants
.
Hematology Am Soc Hematol Educ Program
.
2016
;
2016
:
309
-
315
.
49.
Sud
A
,
Kinnersley
B
,
Houlston
RS
.
Genome-wide association studies of cancer: current insights and future perspectives
.
Nat Rev Cancer
.
2017
;
17
(
11
):
692
-
704
.
50.
Goldin
LR
,
Björkholm
M
,
Kristinsson
SY
,
Turesson
I
,
Landgren
O
.
Highly increased familial risks for specific lymphoma subtypes
.
Br J Haematol
.
2009
;
146
(
1
):
91
-
94
.
51.
Kristinsson
SY
,
Björkholm
M
,
Goldin
LR
,
McMaster
ML
,
Turesson
I
,
Landgren
O
.
Risk of lymphoproliferative disorders among first-degree relatives of lymphoplasmacytic lymphoma/Waldenstrom macroglobulinemia patients: a population-based study in Sweden
.
Blood
.
2008
;
112
(
8
):
3052
-
3056
.
52.
Goldin
LR
,
Pfeiffer
RM
,
Li
X
,
Hemminki
K
.
Familial risk of lymphoproliferative tumors in families of patients with chronic lymphocytic leukemia: results from the Swedish Family-Cancer Database
.
Blood
.
2004
;
104
(
6
):
1850
-
1854
.
53.
Landgren
O
,
Linet
MS
,
McMaster
ML
,
Gridley
G
,
Hemminki
K
,
Goldin
LR
.
Familial characteristics of autoimmune and hematologic disorders in 8,406 multiple myeloma patients: a population-based case-control study
.
Int J Cancer
.
2006
;
118
(
12
):
3095
-
3098
.
54.
Landgren
O
,
Goldin
LR
,
Kristinsson
SY
,
Helgadottir
EA
,
Samuelsson
J
,
Björkholm
M
.
Increased risks of polycythemia vera, essential thrombocythemia, and myelofibrosis among 24,577 first-degree relatives of 11,039 patients with myeloproliferative neoplasms in Sweden
.
Blood
.
2008
;
112
(
6
):
2199
-
2204
.
55.
Frank
C
,
Fallah
M
,
Chen
T
, et al
.
Search for familial clustering of multiple myeloma with any cancer
.
Leukemia
.
2016
;
30
(
3
):
627
-
632
.
56.
Hemminki
K
,
Li
X
,
Plna
K
,
Granström
C
,
Vaittinen
P
.
The nation-wide Swedish family-cancer database--updated structure and familial rates
.
Acta Oncol
.
2001
;
40
(
6
):
772
-
777
.
57.
Ji
J
,
Sundquist
K
,
Sundquist
J
,
Hemminki
K
.
Comparability of cancer identification among Death Registry, Cancer Registry and Hospital Discharge Registry
.
Int J Cancer
.
2012
;
131
(
9
):
2085
-
2093
.
58.
Hemminki
K
,
Ji
J
,
Brandt
A
,
Mousavi
SM
,
Sundquist
J
.
The Swedish Family-Cancer Database 2009: prospects for histology-specific and immigrant studies
.
Int J Cancer
.
2010
;
126
(
10
):
2259
-
2267
.
59.
Leu
M
,
Reilly
M
,
Czene
K
.
Evaluation of bias in familial risk estimates: a study of common cancers using Swedish population-based registers
.
J Natl Cancer Inst
.
2008
;
100
(
18
):
1318
-
1325
.
60.
Andrieu
N
,
Launoy
G
,
Guillois
R
,
Ory-Paoletti
C
,
Gignoux
M
.
Estimation of the familial relative risk of cancer by site from a French population based family study on colorectal cancer (CCREF study)
.
Gut
.
2004
;
53
(
9
):
1322
-
1328
.
61.
Czene
K
,
Adami
H-O
,
Chang
ET
.
Sex- and kindred-specific familial risk of non-Hodgkin’s lymphoma
.
Cancer Epidemiol Biomarkers Prev
.
2007
;
16
(
11
):
2496
-
2499
.
62.
Ford
AM
,
Ridge
SA
,
Cabrera
ME
, et al
.
In utero rearrangements in the trithorax-related oncogene in infant leukaemias
.
Nature
.
1993
;
363
(
6427
):
358
-
360
.
64.
Alter
BP
.
Fanconi anemia and the development of leukemia
.
Best Pract Res Clin Haematol
.
2014
;
27
(
3-4
):
214
-
221
.
65.
Vlachos
A
,
Rosenberg
PS
,
Atsidaftos
E
,
Alter
BP
,
Lipton
JM
.
Incidence of neoplasia in Diamond Blackfan anemia: a report from the Diamond Blackfan Anemia Registry
.
Blood
.
2012
;
119
(
16
):
3815
-
3819
.
66.
Alter
BP
,
Giri
N
,
Savage
SA
,
Rosenberg
PS
.
Cancer in dyskeratosis congenita
.
Blood
.
2009
;
113
(
26
):
6549
-
6557
.
67.
Alter
BP
,
Giri
N
,
Savage
SA
,
Rosenberg
PS
.
Cancer in the National Cancer Institute inherited bone marrow failure syndrome cohort after fifteen years of follow-up
.
Haematologica
.
2018
;
103
(
1
):
30
-
39
.
68.
Mai
PL
,
Best
AF
,
Peters
JA
, et al
.
Risks of first and subsequent cancers among TP53 mutation carriers in the National Cancer Institute Li-Fraumeni syndrome cohort
.
Cancer
.
2016
;
122
(
23
):
3673
-
3681
.
69.
Suarez
F
,
Mahlaoui
N
,
Canioni
D
, et al
.
Incidence, presentation, and prognosis of malignancies in ataxia-telangiectasia: a report from the French national registry of primary immune deficiencies
.
J Clin Oncol
.
2015
;
33
(
2
):
202
-
208
.
70.
Houlston
RS
,
Ford
D
.
Genetics of coeliac disease
.
QJM
.
1996
;
89
(
10
):
737
-
743
.
71.
Newman
SC
.
Sample Size and Power. Biostatistical Methods in Epidemiology
. New York:
John Wiley & Sons, Inc.
;
2002
:
281
-
294
.
72.
Hemminki
K
,
Li
X
,
Czene
K
.
Familial risk of cancer: data for clinical counseling and cancer genetics
.
Int J Cancer
.
2004
;
108
(
1
):
109
-
114
.
73.
Frank
C
,
Fallah
M
,
Sundquist
J
,
Hemminki
A
,
Hemminki
K
.
Population landscape of familial cancer
.
Sci Rep
.
2015
;
5
(
1
):
12891
.
74.
Barlow
L
,
Westergren
K
,
Holmberg
L
,
Talbäck
M
.
The completeness of the Swedish Cancer Register: a sample survey for year 1998
.
Acta Oncol
.
2009
;
48
(
1
):
27
-
33
.
75.
Chang
ET
,
Smedby
KE
,
Hjalgrim
H
,
Glimelius
B
,
Adami
H-O
.
Reliability of self-reported family history of cancer in a large case-control study of lymphoma
.
J Natl Cancer Inst
.
2006
;
98
(
1
):
61
-
68
.
76.
Mattsson
B
,
Wallgren
A
.
Completeness of the Swedish Cancer Register. Non-notified cancer cases recorded on death certificates in 1978
.
Acta Radiol Oncol
.
1984
;
23
(
5
):
305
-
313
.
77.
Pukkala
E
,
Engholm
G
,
Højsgaard Schmidt
LK
, et al
.
Nordic Cancer Registries - an overview of their procedures and data comparability
.
Acta Oncol
.
2018
;
57
(
4
):
440
-
455
.
78.
Goldin
LR
,
Kristinsson
SY
,
Liang
XS
,
Derolf
ÅR
,
Landgren
O
,
Björkholm
M
.
Familial aggregation of acute myeloid leukemia and myelodysplastic syndromes
.
J Clin Oncol
.
2012
;
30
(
2
):
179
-
183
.
79.
Speedy
HE
,
Kinnersley
B
,
Chubb
D
, et al
.
Germ line mutations in shelterin complex genes are associated with familial chronic lymphocytic leukemia
.
Blood
.
2016
;
128
(
19
):
2319
-
2326
.
80.
Dokal
I
,
Vulliamy
T
,
Mason
P
,
Bessler
M
.
Clinical utility gene card for: dyskeratosis congenita - update 2015
.
Eur J Hum Genet
.
2015
;
23
(
4
):
558
.
81.
Boocock
GRB
,
Morrison
JA
,
Popovic
M
, et al
.
Mutations in SBDS are associated with Shwachman-Diamond syndrome
.
Nat Genet
.
2003
;
33
(
1
):
97
-
101
.
82.
Skokowa
J
,
Dale
DC
,
Touw
IP
,
Zeidler
C
,
Welte
K
.
Severe congenital neutropenias
.
Nat Rev Dis Primers
.
2017
;
3
(
1
):
17032
.
83.
Song
W-J
,
Sullivan
MG
,
Legare
RD
, et al
.
Haploinsufficiency of CBFA2 causes familial thrombocytopenia with propensity to develop acute myelogenous leukaemia
.
Nat Genet
.
1999
;
23
(
2
):
166
-
175
.
84.
Zhang
MY
,
Churpek
JE
,
Keel
SB
, et al
.
Germline ETV6 mutations in familial thrombocytopenia and hematologic malignancy
.
Nat Genet
.
2015
;
47
(
2
):
180
-
185
.
85.
Malkin
D
,
Li
FP
,
Strong
LC
, et al
.
Germ line p53 mutations in a familial syndrome of breast cancer, sarcomas, and other neoplasms
.
Science
.
1990
;
250
(
4985
):
1233
-
1238
.
86.
Shah
S
,
Schrader
KA
,
Waanders
E
, et al
.
A recurrent germline PAX5 mutation confers susceptibility to pre-B cell acute lymphoblastic leukemia
.
Nat Genet
.
2013
;
45
(
10
):
1226
-
1231
.
87.
de la Chapelle
A
,
Träskelin
AL
,
Juvonen
E
.
Truncated erythropoietin receptor causes dominantly inherited benign human erythrocytosis
.
Proc Natl Acad Sci USA
.
1993
;
90
(
10
):
4495
-
4499
.
88.
Churchman
ML
,
Qian
M
,
Te Kronnie
G
, et al
.
Germline genetic IKZF1 variation and predisposition to childhood acute lymphoblastic leukemia
.
Cancer Cell
.
2018
;
33
(
5
):
937
-
948
.
89.
Vijayakrishnan
J
,
Studd
J
,
Broderick
P
, et al;
PRACTICAL Consortium
.
Genome-wide association study identifies susceptibility loci for B-cell childhood acute lymphoblastic leukemia [published correction appears in Nat Commun. 2019;10(1):419]
.
Nat Commun
.
2018
;
9
(
1
):
1340
.
90.
Halvarsson
B-M
,
Wihlborg
A-K
,
Ali
M
, et al
.
Direct evidence for a polygenic etiology in familial multiple myeloma
.
Blood Adv
.
2017
;
1
(
10
):
619
-
623
.
91.
Law
PJ
,
Sud
A
,
Mitchell
JS
, et al
.
Genome-wide association analysis of chronic lymphocytic leukaemia, Hodgkin lymphoma and multiple myeloma identifies pleiotropic risk loci
.
Sci Rep
.
2017
;
7
(
1
):
41071
.
92.
Went
M
,
Sud
A
,
Speedy
H
, et al
.
Genetic correlation between multiple myeloma and chronic lymphocytic leukaemia provides evidence for shared aetiology
.
Blood Cancer J
.
2018
;
9
(
1
):
1
.
93.
Khoury
MJ
,
Beaty
TH
,
Liang
KY
.
Can familial aggregation of disease be explained by familial aggregation of environmental risk factors?
Am J Epidemiol
.
1988
;
127
(
3
):
674
-
683
.
94.
Aalen
OO
.
Modelling the influence of risk factors on familial aggregation of disease
.
Biometrics
.
1991
;
47
(
3
):
933
-
945
.
95.
Guo
SW
.
Familial aggregation of environmental risk factors and familial aggregation of disease
.
Am J Epidemiol
.
2000
;
151
(
11
):
1121
-
1131
.
96.
Risch
N
.
The genetic epidemiology of cancer: interpreting family and twin studies and their implications for molecular genetic approaches
.
Cancer Epidemiol Biomarkers Prev
.
2001
;
10
(
7
):
733
-
741
.
97.
Little
MP
,
Wakeford
R
,
Borrego
D
, et al
.
Leukaemia and myeloid malignancy among people exposed to low doses (<100 mSv) of ionising radiation during childhood: a pooled analysis of nine historical cohort studies
.
Lancet Haematol
.
2018
;
5
(
8
):
e346
-
e358
.
98.
Vrijheid
M
,
Cardis
E
,
Ashmore
P
, et al;
15-Country Study Group
.
Ionizing radiation and risk of chronic lymphocytic leukemia in the 15-country study of nuclear industry workers
.
Radiat Res
.
2008
;
170
(
5
):
661
-
665
.
99.
Leuraud
K
,
Richardson
DB
,
Cardis
E
, et al
.
Ionising radiation and risk of death from leukaemia and lymphoma in radiation-monitored workers (INWORKS): an international cohort study
.
Lancet Haematol
.
2015
;
2
(
7
):
e276
-
e281
.
100.
de Tute
R
,
Yuille
M
,
Catovsky
D
,
Houlston
RS
,
Hillmen
P
,
Rawstron
AC
.
Monoclonal B-cell lymphocytosis (MBL) in CLL families: substantial increase in relative risk for young adults
.
Leukemia
.
2006
;
20
(
4
):
728
-
729
.
101.
Hinds
DA
,
Barnholt
KE
,
Mesa
RA
, et al
.
Germ line variants predispose to both JAK2 V617F clonal hematopoiesis and myeloproliferative neoplasms
.
Blood
.
2016
;
128
(
8
):
1121
-
1128
.
102.
Bowman
RL
,
Busque
L
,
Levine
RL
.
Clonal hematopoiesis and evolution to hematopoietic malignancies
.
Cell Stem Cell
.
2018
;
22
(
2
):
157
-
170
.
103.
Kralovics
R
,
Stockton
DW
,
Prchal
JT
.
Clonal hematopoiesis in familial polycythemia vera suggests the involvement of multiple mutational events in the early pathogenesis of the disease
.
Blood
.
2003
;
102
(
10
):
3793
-
3796
.
104.
Steensma
DP
,
Bejar
R
,
Jaiswal
S
, et al
.
Clonal hematopoiesis of indeterminate potential and its distinction from myelodysplastic syndromes
.
Blood
.
2015
;
126
(
1
):
9
-
16
.
105.
Thomsen
H
,
Chattopadhyay
S
,
Weinhold
N
, et al
.
Genome-wide association study of monoclonal gammopathy of unknown significance (MGUS): comparison with multiple myeloma
.
Leukemia
.
2019
;
33
(
7
):
1817
-
1821
.
106.
Landgren
O
,
Kristinsson
SY
,
Goldin
LR
, et al
.
Risk of plasma cell and lymphoproliferative disorders among 14621 first-degree relatives of 4458 patients with monoclonal gammopathy of undetermined significance in Sweden
.
Blood
.
2009
;
114
(
4
):
791
-
795
.
107.
Vachon
CM
,
Kyle
RA
,
Therneau
TM
, et al
.
Increased risk of monoclonal gammopathy in first-degree relatives of patients with multiple myeloma or monoclonal gammopathy of undetermined significance
.
Blood
.
2009
;
114
(
4
):
785
-
790
.
108.
Humphreys
K
,
Grankvist
A
,
Leu
M
, et al
.
The genetic structure of the Swedish population
.
PLoS One
.
2011
;
6
(
8
):
e22547
.
109.
Ameur
A
,
Dahlberg
J
,
Olason
P
, et al
.
SweGen: a whole-genome data resource of genetic variability in a cross-section of the Swedish population
.
Eur J Hum Genet
.
2017
;
25
(
11
):
1253
-
1260
.
110.
Hemminki
K
,
Granström
C
,
Chen
B
.
The Swedish family-cancer database: update, application to colorectal cancer and clinical relevance
.
Hered Cancer Clin Pract
.
2005
;
3
(
1
):
7
-
18
.
111.
Bray
F
,
Ferlay
J
,
Soerjomataram
I
,
Siegel
RL
,
Torre
LA
,
Jemal
A
.
Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries
.
CA Cancer J Clin
.
2018
;
68
(
6
):
394
-
424
.
112.
Li
N
,
Johnson
DC
,
Weinhold
N
, et al
.
Genetic predisposition to multiple myeloma at 5q15 Is mediated by an ELL2 enhancer polymorphism
.
Cell Reports
.
2017
;
20
(
11
):
2556
-
2564
.
113.
Studd
JB
,
Vijayakrishnan
J
,
Yang
M
,
Migliorini
G
,
Paulsson
K
,
Houlston
RS
.
Genetic and regulatory mechanism of susceptibility to high-hyperdiploid acute lymphoblastic leukaemia at 10p21.2 [published correction appears in Nat Commun. 2018;9:16204]
.
Nat Commun
.
2017
;
8
(
1
):
14616
.
114.
Kandaswamy
R
,
Sava
GP
,
Speedy
HE
, et al
.
Genetic predisposition to chronic lymphocytic leukemia is mediated by a BMF super-enhancer polymorphism
.
Cell Reports
.
2016
;
16
(
8
):
2061
-
2067
.
115.
Li
N
,
Johnson
DC
,
Weinhold
N
, et al
.
Multiple myeloma risk variant at 7p15.3 creates an IRF4-binding site and interferes with CDCA7L expression
.
Nat Commun
.
2016
;
7
(
1
):
13656
.
116.
Studd
JB
,
Yang
M
,
Li
Z
, et al
.
Genetic predisposition to B-cell acute lymphoblastic leukemia at 14q11.2 is mediated by a CEBPE promoter polymorphism
.
Leukemia
.
2019
;
33
(
1
):
1
-
14
.
117.
Stensrud
MJ
,
Valberg
M
.
Inequality in genetic cancer risk suggests bad genes rather than bad luck
.
Nat Commun
.
2017
;
8
(
1
):
1165
.
118.
Turnbull
C
,
Sud
A
,
Houlston
RS
.
Cancer genetics, precision prevention and a call to action [published correction appears in Nat Genet. 2019;51(1):196]
.
Nat Genet
.
2018
;
50
(
9
):
1212
-
1218
.
You do not currently have access to this content.